Seelos Therapeutics Appoints Richard Pascoe As Chairman Of The Board

Biopharmaceutical company Seelos Therapeutics, Inc. (SEEL) announced Monday the receipt of minutes from its End of Phase II Meeting with the U.S. Food and Drug Administration or FDA that highlights the modifications to the primary and secondary endpoints of its Phase II Study of SLS-002.

A report released by payroll processor ADP on Wednesday showed private sector job growth in the U.S. slowed by more than expected in the month of May.

Eli Lilly and Co. (LLY) announced Wednesday that Anat Ashkenazi has resigned as chief financial officer to pursue a career opportunity outside of the pharmaceutical industry.

Biotech company I-Mab (IMAB) announced Wednesday that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMY).

Canadian shares look headed for a positive start Wednesday morning thanks to positive global cues. The focus will be the Bank of Canada's interest rate decision.

Consumer price inflation in the Philippines is consistent with existing projections and is likely to exceed the target range temporarily in the coming months, due to the impact of adverse weather on domestic agricultural output and positive base effects, the country's central bank Bangko Sentral ng Pilipinas said Wednesday.

The Japanese yen weakened against other major currencies in the European session on Wednesday, as investors looked ahead to Thursday's ECB meeting and the release of U.S. labor market data on Friday for directional cues.

While reporting financial results for the third quarter on Wednesday, United Natural Foods, Inc. (UNFI) raised its adjusted bottom line results guidance for the full-year 2024, while maintaining annual net sales outlook.